These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3556259)

  • 41. The assembly and secretion of apoB-100-containing lipoproteins.
    Borén J; Wettesten M; Rustaeus S; Andersson M; Olofsson SO
    Biochem Soc Trans; 1993 May; 21(2):487-93. PubMed ID: 8359516
    [No Abstract]   [Full Text] [Related]  

  • 42. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional domains of apolipoprotein E and apolipoprotein B.
    Innerarity TL; Weisgraber KH; Rall SC; Mahley RW
    Acta Med Scand Suppl; 1987; 715():51-9. PubMed ID: 3035881
    [No Abstract]   [Full Text] [Related]  

  • 44. Insulin suppression of VLDL apo B secretion is not mediated by the LDL receptor.
    Chirieac DV; Cianci J; Collins HL; Sparks JD; Sparks CE
    Biochem Biophys Res Commun; 2002 Sep; 297(1):134-7. PubMed ID: 12220520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
    März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
    J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Site-specific modification of apolipoprotein B by advanced glycosylation end-products: implications for lipoprotein clearance and atherogenesis.
    Bucala R
    Nephrol Dial Transplant; 1996; 11 Suppl 5():17-9. PubMed ID: 9044301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinetic studies of the origin of apolipoprotein (apo) B-100 in low density lipoproteins of normal and Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Havel RJ; Shames DM
    Adv Exp Med Biol; 1991; 285():245-55. PubMed ID: 1858553
    [No Abstract]   [Full Text] [Related]  

  • 48. The molecular and cell biology of apolipoprotein-B.
    Scott J
    Mol Biol Med; 1989 Feb; 6(1):65-80. PubMed ID: 2666820
    [No Abstract]   [Full Text] [Related]  

  • 49. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.
    Flood C; Gustafsson M; Pitas RE; Arnaboldi L; Walzem RL; Borén J
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):564-70. PubMed ID: 14726411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipoprotein lipases, lipoprotein density gradient profile and LDL receptor activity in miniature pigs fed fish oil and corn oil.
    Huff MW; Telford DE; Edmonds BW; McDonald CG; Evans AJ
    Biochim Biophys Acta; 1993 Dec; 1210(1):113-22. PubMed ID: 8257713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The production and use of monoclonal antibodies to measure apolipoprotein B by a competitive enzyme-linked immunoassay.
    Waterson M; Samuel L; Miller E; Norman M
    Ann Clin Biochem; 1987 May; 24 ( Pt 3)():301-8. PubMed ID: 3111342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of apoB-containing lipoproteins from unfractionated human blood sera to immobilized LDL receptor.
    Yakushkin VV; Tsibulsky VP
    Biochemistry (Mosc); 1998 Oct; 63(10):1164-71. PubMed ID: 9864450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
    Krul ES; Tikkanen MJ; Cole TG; Davie JM; Schonfeld G
    J Clin Invest; 1985 Feb; 75(2):361-9. PubMed ID: 3973009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cloning and expression of apolipoprotein B, the major protein of low and very low density lipoproteins.
    Lusis AJ; West R; Mehrabian M; Reuben MA; LeBoeuf RC; Kaptein JS; Johnson DF; Schumaker VN; Yuhasz MP; Schotz MC
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4597-601. PubMed ID: 3860811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of normolipidemic very low density lipoproteins with receptors in human skin fibroblasts.
    Yamamoto M; Ranganathan S; Kottke BA
    Biochem Int; 1985 Oct; 11(4):573-81. PubMed ID: 3853463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular biology: a cholesterol tether.
    Staels B
    Nature; 2002 Jun; 417(6890):699-701. PubMed ID: 12066168
    [No Abstract]   [Full Text] [Related]  

  • 57. Apolipoprotein B gene: plasma cholesterol and atherosclerosis.
    Scott J; Pease RJ; Powell LM; Wallis SC; McCarthy BJ; Mahley RW; Levy-Wilson B; Knott TJ
    Biochem Soc Symp; 1987; 53():155-63. PubMed ID: 3332766
    [No Abstract]   [Full Text] [Related]  

  • 58. Atherogenic lipoproteins resulting from genetic defects of apolipoproteins B and E.
    Weisgraber KH; Innerarity TL; Rall SC; Mahley RW
    Ann N Y Acad Sci; 1990; 598():37-48. PubMed ID: 2248450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100.
    Wei CF; Chen SH; Yang CY; Marcel YL; Milne RW; Li WH; Sparrow JT; Gotto AM; Chan L
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7265-9. PubMed ID: 2932736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxidative modification of a specific apolipoprotein B lysine residue confers altered receptor specificity on LDL.
    Griffiths HR; Wright J; Bevan R; Lunec J
    Redox Rep; 1999; 4(6):337-9. PubMed ID: 10772081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.